Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

Nanocarriers as an emerging platform for cancer therapy

Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710

Recent advances with liposomes as pharmaceutical carriers

Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282

Nanoparticle therapeutics: an emerging treatment modality for cancer

Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233

Delivering nanomedicine to solid tumors

Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,265

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170

Collagens—structure, function, and biosynthesis

Gelse, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.002 · Cited by 2,777

Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome

Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794

Molecular mechanisms of drug resistance

Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,726

Role of extracellular matrix assembly in interstitial transport in solid tumors.

Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165

Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation

Brown, E. B., McKee, T. D., DiTomaso, E., Pluen, A., Seed, B., Boucher, Y., & Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm879 · Cited by 844

Identification of peptide coatings that enhance diffusive transport of nanoparticles through the tumor microenvironment

Mohanty, R. P., Liu, X., Kim, J. Y., Peng, X., Bhandari, S., Leal, J., Arasappan, D., Wylie, D., Dong, T., & Ghosh, D. (2019) · Nanoscale · doi:10.1039/c9nr05783h · Cited by 12

Repurposing Drugs in Small Animal Oncology

Giuliano, A., Horta, R. D. S., Vieira, R. A. D. M., Hume, K. R., & Dobson, J. M. (2022) · Animals · doi:10.3390/ani13010139 · Cited by 14

Current trends and future prospects of drug repositioning in gastrointestinal oncology

Fatemi, N., Karimpour, M., Bahrami, H., Zali, M. R., Chaleshi, V., Riccio, A., Mojarad, E. N., & Totonchi, M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1329244 · Cited by 13

Engineering Microorganisms for Cancer Immunotherapy

Liu, D., Yu, L., Rong, H., Liu, L., & Yin, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304649 · Cited by 13

Depolymerization of Hyaluronan Using PEGylated Human Recombinant Hyaluronidase Promotes Nanoparticle Tumor Penetration

Brundel, D. H. S., Feeney, O. M., Nowell, C. J., Suys, E. J. A., Gracia, G., Kaminskas, L. M., McIntosh, M. P., Kang, D. W., & Porter, C. J. H. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0433 · Cited by 14

Further Understanding of the Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: Implications for Prognosis

Denaro, N., Merlano, M. C., & Nigro, C. L. (2021) · Cancer Management and Research · doi:10.2147/cmar.s277907 · Cited by 13

Impact of tumoral structure and bacterial species on growth and biodistribution of live bacterial therapeutics in xenografted tumours

Takahashi, M., Sukowati, E. W., Nomura, S., Kato, A., Mizuseki, K., Watanabe, Y., & Mukai, H. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2122477 · Cited by 14

Pirfenidone inhibits stromal collagen deposition and improves intra-tumoral delivery and antitumor efficacy of Pegylated liposomal doxorubicin

Cai, T., Jiang, J., Yao, W., Hu, Y., Kong, S., Fan, Q., Yan, X., Li, F., & Shi, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114015 · Cited by 13

In Vitro and In Vivo Tumor Models for the Evaluation of Anticancer Nanoparticles

Abreu, T. R., Biscaia-Caleiras, M., Gonçalves, N., Fonseca, N. A., & Moreira, J. N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-58174-9_12 · Cited by 14

Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?

Kokkinos, J., Jensen, A., Sharbeen, G., McCarroll, J. A., Goldstein, D., Haghighi, K. S., & Phillips, P. A. (2021) · Cancers · doi:10.3390/cancers13102427 · Cited by 14

Heterocellular crosstalk and architecture of the pancreatic tumour microenvironment

Arnold, F., Vecchio, A. D., Hussain, Z., & Sherman, M. H. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-025-00905-9 · Cited by 15

The Role of the Microenvironment in Tumor Initiation, Progression, and Metastasis

Ghajar, C. M., Correia, A. L., & Bissell, M. J. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00016-0 · Cited by 11

Cancer nanomedicine from a clinician-scientist perspective: Lessons and prospects

Gabizón, A. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113731 · Cited by 12

Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?

Watt, D. M., & Morton, J. P. (2021) · Cancers · doi:10.3390/cancers13194984 · Cited by 12

Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer

Gautam, S. K., Dalal, V., Sajja, B. R., Gupta, S., Gulati, M., Dwivedi, N. V., Aithal, A., Cox, J. L., Rachagani, S., Liu, Y., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215801 · Cited by 12

Effect of acoustic cluster therapy (ACT®) combined with chemotherapy in a patient-derived xenograft mouse model of pancreatic cancer

Ng, S., Healey, A. J., Sontum, P. C., Kvåle, S., TORP, S. H., Sulheim, E., Hoff, D. D. V., & Han, H. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.016 · Cited by 12

Perspective: Biophysical regulation of cancerous and normal blood cell lineages in hematopoietic malignancies

Wong, S. W., Lenzini, S. B., & Shin, J. (2018) · APL Bioengineering · doi:10.1063/1.5025689 · Cited by 12

Involvement of angiotensin II receptor type 1/NF‑κB signaling in the development of endometriosis

Zhang, Z., Yuan, Y., Lian, H., Yao, X., & Chen, J. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9071 · Cited by 12

Current Status of Research on Losartan in Tumour Therapy

Wang, H., Yuan, S., & Wang, H. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70985 · Cited by 11

Engineered upconversion nanoparticles for breast cancer theranostics

Wang, S., Zhang, L., Wang, M., Yin, X.-M., Dong, X., Wu, X., Li, W., Xu, W., & Mao, X. (2025) · Theranostics · doi:10.7150/thno.116153 · Cited by 11

Optimizing therapeutic outcomes with Mechanotherapy and Ultrasound Sonopermeation in solid tumors

Koutsi, M., Stylianopoulos, T., & Mpekris, F. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012676 · Cited by 11

Comparative transcriptome of normal and cancer-associated fibroblasts

Abikar, A., Mustafa, M., Athalye, R. R., Nadig, N., Tamboli, N., Babu, V., Keshavamurthy, R., & Ranganathan, P. (2024) · BMC Cancer · doi:10.1186/s12885-024-13006-x · Cited by 11

Combination of Losartan and Platinum Nanoparticles with Photothermal Therapy Induces Immunogenic Cell Death Effective Against Neuroblastoma

Zhang, X., Zhao, Y., Teng, Z., Sun, T., Tao, J., Wu, J., Wang, Y., Qiu, F., & Wang, F. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s467968 · Cited by 12

Microgravity influenced unsteady dispersion during magnetic drug targeting in an inclined tumor-stenosed microvessel with slip effects

Mashiku, L. R., & Shaw, S. (2024) · Chinese Journal of Physics · doi:10.1016/j.cjph.2024.10.010 · Cited by 11

A responsive cocktail nano-strategy breaking the immune excluded state enhances immunotherapy for triple negative breast cancer

Yang, J., Chen, M., Li, R., Sun, Y., Ye, P., Fang, K., Wang, C., Shi, S., & Dong, C. (2025) · Nanoscale · doi:10.1039/d4nr03054k · Cited by 12

Antifibrotic Therapy Augments the Antitumor Effects of Vesicular Stomatitis Virus Via Reprogramming Tumor Microenvironment

Chen, Y., Hu, S., Shu, Y., Qi, Z., Zhang, B., Kuang, Y., Ma, J., & Cheng, P. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.048 · Cited by 11

Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment

Zhou, Y., Xu, L., Wang, Z., Liu, H., Zhang, X., Shu, C., Zhang, M., Wang, T., Xu, X., Pu, X., et al. (2022) · Theranostics · doi:10.7150/thno.70557 · Cited by 11

Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of AGTR1+CAFs in intrahepatic cholangiocarcinoma

Li, J., Wu, X. F., Ni, X., Li, Y.-X., Xu, L., Hao, X., Zhao, W., Zhu, X., & Yin, X. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1213 · Cited by 11

A dual drug-loaded peptide system with morphological transformation prolongs drug retention and inhibits breast cancer growth

Zhai, X., Tang, S., Meng, F., Ma, J., Li, A., Zou, X., Zhou, B., Peng, F., & Bai, J. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213650 · Cited by 10

Surface Modulation of Polymeric Nanocarriers Enhances the Stability and Delivery of Proteins and Small Molecules

Amoozgar, Z., & Goldberg, M. S. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0375 · Cited by 11

Tumor Microenvironment

Jain, R. K., Martin, J. D., Chauhan, V. P., & Duda, D. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00008-6 · Cited by 14

Biologically active Camellia oleifera protein nanoparticles for improving the tumor microenvironment and drug delivery

Qian, X., Shen, T., Zhang, X., Wang, C., Cai, W., Cheng, R., & Jiang, X. (2020) · Biomaterials Science · doi:10.1039/d0bm00516a · Cited by 10

Renin–Angiotensin System in the Tumor Microenvironment

Nakamura, K., Okuyama, R., & Kawakami, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-50224-9_7 · Cited by 12

Reshaping the tumor microenvironment for increasing the distribution of glucose oxidase in tumor and inhibiting metastasis

Geng, S., Lou, R., Yin, Q., Li, S., Yang, R., & Zhou, J. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb02468f · Cited by 11

Light-switchable diphtherin transgene system combined with losartan for triple negtative breast cancer therapy based on nano drug delivery system

Yi, C. X., Sun, R., He, M., Zhang, M., Hou, X., Sun, Y., Wang, J., Xu, J., He, H., Wang, H., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121613 · Cited by 12

An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancer

Tang, H., Abston, E. D., Sojoodi, M., Wang, Y., Erstad, D. J., Lin, Z., Fuchs, B. C., Tanabe, K. K., & Lanuti, M. D. (2024) · JTCVS Open · doi:10.1016/j.xjon.2024.01.014 · Cited by 10

Tumor-stromal opening via S. typhimurium VNP20009 administration for complete inhibition of refractory tumor growth with liposomal anticancer drugs

Kato, A., Nomura, S., Takahashi, M., Sukowati, E. W., Harashima, H., & Mukai, H. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.064 · Cited by 11

Circulating collagen type I fragments as specific biomarkers of cardiovascular outcome risk: Where are the opportunities?

Martin, E. M., Chang, J., González, A., & Genovese, F. (2025) · Matrix Biology · doi:10.1016/j.matbio.2025.03.001 · Cited by 9

Losartan as a mechanotherapeutic adjuvant: Remodeling the breast tumor microenvironment to improve treatment efficacy

Dwairy, M., Yehya, A., Mohammad, F. M., & Alzoubi, H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328196 · Cited by 12

Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress

Brücher, B. L. D. M., & Jamall, I. S. (2019) · 4open · doi:10.1051/fopen/2018996 · Cited by 10

Technological perspectives on laser speckle micro-rheology for cancer mechanobiology research

Hajjarian, Z., & Nadkarni, S. K. (2021) · Journal of Biomedical Optics · doi:10.1117/1.jbo.26.9.090601 · Cited by 11

Transiently hypoxic tumour cell turnover and radiation sensitivity in human tumour xenografts

Wadsworth, B. J., Lee, C.-M., & Bennewith, K. L. (2022) · British Journal of Cancer · doi:10.1038/s41416-021-01691-5 · Cited by 9

Comprehensive analysis of the influence of physicochemical properties and tumor-associated environments on liposome intratumoral penetration

Lin, Z., Deng, T., Liu, Y., Zheng, S., Wang, G., He, H., & Zhang, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.027 · Cited by 11

Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery

Blocker, S. J., & Shields, A. F. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1142-2 · Cited by 10

Magnetophoretic Delivery of a Tumor-Priming Agent for Chemotherapy of Metastatic Murine Breast Cancer

Park, J., Park, J., Castanares, M. A., Collins, D. S., & Yeo, Y. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01148 · Cited by 10

Tumor microenvironment modulation by SERPINE1 increases radioimmunotherapy in murine model of gastric cancer

Zaheer, J., Shanmugiah, J., Kim, S., Kim, H., & Kim, J. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-97983-4 · Cited by 12

Impact of the ECM on the Mechanical Memory of Cancer Cells

Mierke, C. T. (2025) · Cells · doi:10.3390/cells14211707 · Cited by 10

Attenuated Bacteria‐Based Tumor Therapy: Clinical Application Risks, Marketing Approval Restrictions, and Coping Strategies

Liu, Y., Yao, J., Deng, J., Zhou, M., Shen, K., Sun, S., Gao, X., Zhang, Q., & Xu, H. (2026) · Advanced Science · doi:10.1002/advs.202517730 · Cited by 9

Cytoprotective potential of anti-ischemic drugs against chemotherapy-induced cardiotoxicity in H9c2 myoblast cell line

Feridooni, T., Donald, C. M., Shao, D., Yeung, P. K. F., & Agu, R. U. (2013) · Acta Pharmaceutica · doi:10.2478/acph-2013-0038 · Cited by 9

Targeted Osmotic Lysis of Highly Invasive Breast Carcinomas Using Pulsed Magnetic Field Stimulation of Voltage-Gated Sodium Channels and Pharmacological Blockade of Sodium Pumps

Paúl, D., Maggi, P. E., Piero, F. D., Scahill, S. D., Sherman, K. J., Edenfield, S., & Gould, H. J. (2020) · Cancers · doi:10.3390/cancers12061420 · Cited by 9

Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models

Mainetti, L. E., Rico, M. J., Kaufman, C. D., Grillo, M. C., Guercetti, J., Baglioni, M. V., Giúdice, A. D., Capitani, M. C., Fusini, M. E., Rozados, V. R., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27694 · Cited by 9

Angiotensin II Type 1 Receptor Antagonist Losartan Inhibits TNF-α-Induced Inflammation and Degeneration Processes in Human Nucleus Pulposus Cells

Saravi, B., Li, Z., Pfannkuche, J., Wystrach, L., Häckel, S., Albers, C. E., Grad, S., Alini, M., Richards, R. G., Lang, C. N., et al. (2021) · Applied Sciences · doi:10.3390/app11010417 · Cited by 9

Tumor Microenvironment‐Related Sonodynamic Therapy Mediates Tumor Therapy

Wang, X., Wang, C., Tian, H., Wu, B., & Cheng, W. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300265 · Cited by 9

Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

Labenz, C., Prenosil, V., Koch, S., Huber, Y., Marquardt, J. U., Schattenberg, J. M., Galle, P. R., Weinmann, A., & Wörns, M. (2017) · Digestive Diseases · doi:10.1159/000477578 · Cited by 9

Engineering Nanosensitizer to Remodel the TME for Hypoimmunogenic “Cold”–“Hot” Tumor Transformations

Liu, Z., Wang, Z., Zhang, Z., Zhang, Z., Qi, X., Zhu, H., Zhang, K., Qu, T., Zhao, Y., Kang, Z., et al. (2024) · Nano Letters · doi:10.1021/acs.nanolett.3c03816 · Cited by 8

Leveraging insights from cancer to improve tuberculosis therapy

Datta, M., Via, L. E., Dartois, V. A., Xu, L., Barry, C. E., & Jain, R. K. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.07.011 · Cited by 11

Biophysical and Epigenetic Regulation of Cancer Stemness, Invasiveness, and Immune Action

Veerasubramanian, P. K., Trinh, A., Akhtar, N., Liu, W. F., & Downing, T. L. (2020) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-020-00021-w · Cited by 8

Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model

Price, L., Rivera, J. N., Madden, A. J., Herity, L. B., Piscitelli, J. A., Mageau, S., Santos, C., Roques, J., Midkiff, B. R., Feinberg, N. N., et al. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211053700 · Cited by 8

Progress and Hurdles of Therapeutic Nanosystems against Cancer

Martín-Contreras, M., Navarro-Marchal, S. A., Peula-García, J. M., & Jódar‐Reyes, A. B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020388 · Cited by 9

Pressure Gradients in Solid Tumors

Stapleton, S., & Milosevic, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7876-8_9 · Cited by 8

AT 1 receptor blockade delays postlactational mammary gland involution: a novel role for the renin angiotensin system

Nahmod, K. A., Walther, T., Cambados, N., Fernández, N., Meiss, R. P., Tappenbeck, N., Wang, Y., Raffo, D., Simian, M., Schwiebs, A., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-191932 · Cited by 8

Tumour-fighting virus homes in

Galanis, E. (2011) · Nature · doi:10.1038/477040a · Cited by 8

Sequential Drug Release to Modulate Collagen Synthesis and Promote Micelle Penetration in Tumors

Chen, Z., Liu, W., Wang, X., Liu, Y., & Li, X. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01600 · Cited by 8

Autophagy inhibition alleviates tumor desmoplasia and improves the efficacy of locally and systemically administered liposomal doxorubicin

Sandha, K. K., Kaur, S., Sharma, K., Ali, S. M., Ramajayan, P., Kumar, A., & Gupta, P. N. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.12.078 · Cited by 7

Mechano-regulation of cancer cell memory in tumor progression and therapy

Qu, Y., Cui, J., Wu, Z., He, P., Wei, F., Guo, T., Huang, Y., Yu, X., Tsoy, M., Liu, K., et al. (2025) · Mechanobiology in Medicine · doi:10.1016/j.mbm.2025.100165 · Cited by 7

Awakening Allies for Breaking Microenvironment Barriers: NIR‐II Guided Orthogonal Activation of Tumor‐Infiltrating Mast Cells for Efficient Nano‐Drug Delivery

Wang, Q., Yang, H., Liu, Y., Zhou, Z., Zhang, X., Sang, M., Xu, F., Song, L., Xia, T., Zhang, Y., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300420 · Cited by 7

Cancer-associated fibroblasts in neoadjuvant setting for solid cancers

Gu, Y., Chen, Q., Yin, H., Zeng, M., Gao, S., & Wang, X. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104226 · Cited by 7

Therapeutic In Situ Cancer Vaccine Using Pulsed Stereotactic Body Radiotherapy—A Translational Model

Swamy, K. (2023) · Vaccines · doi:10.3390/vaccines12010007 · Cited by 6

Antiglioma Oncolytic Virotherapy: Unattainable Goal or a Success Story in the Making?

Dey, M., Auffinger, B., Lesniak, M. S., & Ahmed, A. U. (2013) · Future Virology · doi:10.2217/fvl.13.47 · Cited by 7

Clinical factors related to severe enterocolitis after adjuvant CAPOX for colorectal cancer: a retrospective analysis

Felismino, T. C., de Jesus, V. H. F., Uchôa, B. C. D. M., Moura, F. G. R., Riechelmann, R. P., Aguiar, S., & de Mello, C. A. L. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1014 · Cited by 7

Exploration of Different Hypoxia Patterns and Construction of a Hypoxia-Related Gene Prognostic Index in Colorectal Cancer

Bai, S., Chen, L., Yan, Y., Li, R., Zhou, Y., Wang, X., Kang, H., Feng, Z., Li, G., Zhou, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.853352 · Cited by 8

Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis

Lu, S., Yin, Z., Chen, J., Wu, L., Sun, Y., Gao, X., Huang, P., Jordan, J. T., Plotkin, S. R., & Xu, L. (2024) · Cancers · doi:10.3390/cancers16111961 · Cited by 6

Chronic compression induces transcriptional, metabolic, and functional state changes in macrophages that recapitulate tumor-associated phenotypes

Burchett, A. A., Chen, H., Najera, J., Howard, S. S., & Datta, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1626024 · Cited by 6

Smart Cancer Nanomedicine for Synergetic Therapy

Kanungo, A., Mohanty, C., & Acharya, S. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673300897240602130258 · Cited by 6

Biologically based strategies for overcoming in vivo barriers with functional nano‐delivery systems

Ahmadzadeh, R., Taheri, S. A., Mohammadi, N., Hjazi, A. M., Menon, S. V., Kadhum, W. R., Kumar, A., Shakir, M. N., Shayan, F. K., & Shirinkami, N. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23782 · Cited by 6

Bio-fabrication of chitosan-stabilized magnesium oxide nanomaterials: Investigation of photocatalytic, in vitro cytotoxicity activities and apoptosis in oral squamous carcinoma cells

Govindasamy, C., Khan, M. I., Hussein‐Al‐Ali, S. H., Abualassal, Q. I. A., Abudayeh, Z. H. M., Arulselvan, P., Bharathi, M., & Surya, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.139926 · Cited by 6

Thermosensitive Hydrogel Loaded with α-Mangostin for Enhanced Antitumor Effect of Doxorubicin

Liu, T., Wang, Q., Geng, W., Jiang, X., Lu, C., Zhang, Z., & Feng, X. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c02408 · Cited by 6

The dependence of efficiency of transmembrane molecular transfer using electroporation on medium viscosity

Sungailaitė, S., Ruzgys, P., Šatkauskienė, I., Čepurnienė, K., & Šatkauskas, S. (2015) · The Journal of Gene Medicine · doi:10.1002/jgm.2825 · Cited by 6

Disrupting stromal barriers to enhance photothermal-chemo therapy using a halofuginone-loaded Janus mesoporous nanoplatform

Tang, R., Dang, M., Zhang, X., Tao, J., Shi, W., Lu, W. M., Yu, R., Su, X., Tang, Y., & Teng, Z. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.11.190 · Cited by 6

Antifibrotic Agent Mediated Tumor Microenvironment Modulation and Improved Nanomedicine Delivery in Solid Tumor

Sandha, K. K., Behera, C., Chibber, P., Kumar, R., Kumar, A., Mondhe, D. M., Singh, G., & Gupta, P. N. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c01081 · Cited by 6

Enhancement of treatment efficacy of hepatic tumours using Trans-arterial-chemoembolization.

Pillai, K., Ke, K., Mekkawy, A. H., Akhter, J., & Morris, D. L. (2023) · PubMed Central · Cited by 10

Targets in the Tumour Matrisome to Promote Cancer Therapy Response

Jalil, S. M. A., Henry, J. C., & Cameron, A. J. M. (2024) · Cancers · doi:10.3390/cancers16101847 · Cited by 8

Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility

Imani, J., Bodine, S. P., Lamattina, A. M., Ma, D. D., Shrestha, S., Maynard, D., Bishop, K. S., Nwokeji, A., Malicdan, M. C. V., Testa, L. C., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02083-w · Cited by 6

Targeting gallbladder cancer: hyaluronan sensitizes cancer cells to chemo-therapeutics.

Ma, M., Weng, M., Zhang, M., Qin, Y., Gong, W., & Quan, Z. (2015) · Europe PMC (PubMed Central) · Cited by 6

PYCR1-dependent proline synthesis in cancer-associated fibroblasts is required for the deposition of pro-tumorigenic extracellular matrixPreprint

Kay, E. J., Paterson, K., Domingo, C. R., Sumpton, D. P., Daebritz, H., Tardito, S., Boldrini, C., Hernandez-Fernaud, J. R., Athineos, D., Dhayade, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.30.125237 · Cited by 6

Renin-angiotensin system inhibitors and survival in patients with renal cell carcinoma: Evidence from a meta-analysis

Xi, H., Zhao, M., & Shen, J. (2025) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2025.05.015 · Cited by 5

Synergistic mechanotherapy and sonopermeation guided by mathematical modeling for solid tumor treatment

Koutsi, M., Stylianopoulos, T., & Mpekris, F. (2025) · Frontiers in Drug Delivery · doi:10.3389/fddev.2025.1549098 · Cited by 6

Implantable Light Source‐Integrated Microneedles for Losartan‐Enhanced and Sustained Photodynamic Therapy of Tumors

Lin, M., Kang, X., Liu, F., Nie, J., Zhang, J., Zhuang, J., Yu, B., & Xu, F. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202513208 · Cited by 5

Drug Repurposing in Veterinary Oncology: Myth or Reality?

Ciccarelli, S., Perrone, C., Cavalera, M. A., & Giuliano, A. (2025) · Veterinary Sciences · doi:10.3390/vetsci12111067 · Cited by 5

Therapeutic targets in the pancreatic adenocarcinoma microenvironment: past challenges and opportunities for the future

Tsang, E. S., & Tempero, M. A. (2021) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2021.22 · Cited by 5

The effect of mechanical force in genitourinary malignancies

Huang, K., Liu, J., Chen, Q., Feng, D., Wu, H., Al-Danakh, A., Jian, Y., Xu, Z., Wang, S., & Yang, D. (2021) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2022.2000864 · Cited by 5

The use of angiotensin system inhibitors correlates with longer survival in resected pancreatic adenocarcinoma patients

Liu, H., Nassour, I., Lebowitz, S., D’Alesio, M., Hampton, E. D., DeSilva, A., Hammad, A. Y., AlMasri, S. S., Khachfe, H. H., Singhi, A. D., et al. (2022) · HPB · doi:10.1016/j.hpb.2022.12.002 · Cited by 5

An agarose-alginate microfluidic device for the study of spheroid invasion, ATRA inhibits CAFs-mediated matrix remodeling

Nasiraee, M. R., Shahrivari, S., Sayad, S., Mahdavi, H., Saraygord‐Afshari, N., & Bagheri, Z. (2023) · Cytotechnology · doi:10.1007/s10616-023-00578-y · Cited by 5

Proceedings for OctoberCEST, the third international workshop on CEST imaging, 15–17 October 2012

(2013) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1522 · Cited by 5

Extracellular Matrix Degrading Enzymes for Nanocarrier-Based Anticancer Therapy

Scodeller, P. (2016) · Fundamental biomedical technologies · doi:10.1007/978-3-319-43525-1_3 · Cited by 5

BQ123 selectively improved tumor perfusion and enhanced nanomedicine delivery for glioblastomas treatment

Zhang, B., Wang, H., Jin, K., Jiang, T., Shen, S., Luo, Z., Tuo, Y., Jiang, X., Liu, X., Hu, Y., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.017 · Cited by 6

Normalizing the Tumor Microenvironment for Radiosensitization

Martin, J. D., & Jain, R. K. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_12 · Cited by 5

Nanotechnology: Concepts and Potential Applications in Medicine

Crisóstomo, L. C. C. F., Nogueira, K. A. B., Martins, J. R. P., Santos, E. D. S., de Freitas, P. G. C., Nogueira, B. A. B., Raspantini, G. L., Petrilli, R., & Eloy, J. O. (2021) · Materials horizons · doi:10.1007/978-981-33-6056-3_1 · Cited by 5

Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists’ arsenal

Papanagnou, P., Baltopoulos, P., & Tsironi, M. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s82049 · Cited by 5

Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer

Xia, T., He, Q., Shi, K., Wang, Y., Yu, Q., Zhang, L., Zhang, Q., Gao, H., Ma, L., & Liu, J. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1265553 · Cited by 51

A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan

Cun, X., Ruan, S., Chen, J., Zhang, L., Li, J., He, Q., & Gao, H. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.002 · Cited by 115

Depletion of collagen by losartan to improve tumor accumulation and therapeutic efficacy of photodynamic nanoplatforms

Tang, Y., Liu, Y., Wang, S., Tian, Y., Li, Y., Teng, Z., & Lu, G. (2019) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-00610-1 · Cited by 31

Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity

Yu, M., Zhang, C., Tang, Z., Tang, X., & Xu, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.011 · Cited by 51

High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer

Zhang, L., Wang, Y., Yang, Y., Liu, Y., Ruan, S., Zhang, Q., Tai, X., Chen, J., Xia, T., Qiu, Y., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b01473 · Cited by 108